1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX

Neurocrine Biosciences, Inc. Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

Read More
145.66 2.93 (2.05%)
72.93% Gain from 52W Low
788.9K
XNAS Volume

XNAS 18 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
33.3 / 100
Momentum Score
Technically Moderately Bullish
68.2 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
168
1Yr Price target upside is 16%
26 analysts

27

S

6

W

2

O

1

T

SWOT Analysis

Neurocrine Biosciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..